Surmodics | SRDX - Market Capitalization


Surmodics reported $393.5M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
Artivion USD 2.18B 176M Dec/2025
Baxter International USD 8.67B 1.15B Mar/2026
Boston Scientific USD 93.26B 48.09B Mar/2026
EDAP TMS EUR 73M 11M Sep/2025
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Haemonetics USD 2.66B 1.1B May/2026
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Option Care Health USD 4.23B 831M Mar/2026
Stryker USD 125.85B 8.57B Mar/2026